ArticleDermatology and therapy2026

Cost-Effectiveness Analysis of Bimekizumab against Interleukin-23 Inhibitors in Patients with Plaque Psoriasis in Japan.

Atsuyuki Igarashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.